Combination of LC-Q-TOF-MS/MS, network pharmacology, and nanoemulsion approaches identifies active compounds of two Artemisia species responsible for tackling early diabetes-related metabolic complications in the liver.
Hichem MoulahoumFaezeh GhorbanizamaniZineb KhiariMohamed ToumiYasmina BenazzougSuna TimurFigen ZihniogluPublished in: Phytochemical analysis : PCA (2022)
The current report highlights the potential of Artemisia phytoniosomes as strong contenders in AGE-related disease therapy.
Keyphrases
- mass spectrometry
- type diabetes
- cardiovascular disease
- multiple sclerosis
- genome wide
- ms ms
- glycemic control
- risk factors
- simultaneous determination
- human health
- liquid chromatography
- stem cells
- dna methylation
- risk assessment
- gene expression
- adipose tissue
- insulin resistance
- mesenchymal stem cells
- cell therapy
- skeletal muscle
- solid phase extraction
- weight loss